Biotech China 2014
12th Central-European Lung Cancer Conference
Kempinski Hotel Corvinus Budapest
H-1051 Budapest, Erzsébet tér 7 – 8
Budapest , Hungary
http://www.celcc2010-budapest.hu/

Schedule of Presentations:

Thursday, December 2, 2010
12:10:00 Clinical impact from molecular research Robert Pirker
14:00:00 Opening Petr Zatloukal, Robert Pirker, Gyula Ostoros
14:05:00 Plenary opening session | Molecular biology of lung cancer Robert Pirker, Gyula Ostoros
14:25:00 Lung cancer in never-smokers Gyula Ostoros
14:45:00 Proffered presentation
15:00:00 Proffered presentation
15:15:00 Proffered presentation
15:30:00 Coffee break
16:00:00 Chemo- and targeted therapies in advanced NSCLC Matjaz Zwitter, Nick Thatcher
16:05:00 Novel prospects in cytotoxic chemotherapy Nick Thatcher
16:25:00 Potential molecular targets in the therapy of NSCLC Rolf A. Stahel
16:30:00 Proffered presentation
17:00:00 Proffered presentation
17:15:00 Proffered presentation
17:30:00 Expanding Horizons of Targeted Agents in the Treatment of NSCLC Robert Pirker
17:35:00 Welcome and introduction Robert Pirker
17:40:00 Maximizing efficacy of the first-line treatment of NSCLC Rolf A. Stahel
17:50:00 The emerging role of maintenance treatment - whom to treat? Federico Capuzzo
18:05:00 EGFR inhibition in clinical practice - optimizing second line treatment of NSCLC Gyula Ostoros
18:20:00 Discussion
19:00:00 Welcome party
Friday, December 3, 2010
08:00:00 Meet the professor: Molecular Signatures of NSCLC: Potential Clinical Applications Helmut H. Poppe
09:00:00 Paradigm shift in lung cancer diagnostics Helmut H. Poppe, james L. Mulshine
09:05:00 Molecular diagnostics: from bench to bedside Federico Cappuzzo
09:25:00 Tumor sampling in the era of molecular diagnostics Janos L. Strausz
09:45:00 Proffered presentation
10:00:00 Proffered presentation
10:15:00 Proffered presentation
10:30:00 Coffee break
11:00:00 Radio-chemotherapy in NSCLC Akos Horvath, Petr Zatloukal
11:05:00 Optimization of chemoradiotherapy in unresectable locally advanced NSCLC Jacek Jassem
11:25:00 Chemoradiotherapy in the neoadjuvant setting Wilfried Eberhardt
11:45:00 Proffered presentation
12:00:00 Optimalized therapeutic options for patients with advanced NSCLC Gyula Ostoros, Johan Vansteenkiste
12:05:00 Considerations of Personalized Therapy in Frontline Treatment of Metastatic NSCLC Nick Thatcher
12:15:00 Transitioning From First- to Second-Line Therapy: The Role of Maintenance Treatment Tudor Ciulanu
12:30:00 The Changing Treatment Paradigm in NSCLC – Towards an Individualized Therapy for Stage IIIB / IV Patients Johan Vansteenkiste
12:45:00 Q&A Session and Concluding Remarks
13:00:00 LUNCH
14:00:00 Translational research Glen J. Weiss, Balazs Dome
14:05:00 Application of miRNAs in lung cancer Glen J. Weiss
14:25:00 Biomarkers for adjuvant chemotherapy in patients with completely resected NSCLC Martin Filipits
14:45:00 Proffered presentation
15:00:00 Proffered presentation
15:15:00 Proffered presentation
15:30:00 Coffee break
16:00:00 Operable NSCLC Attila Csekeo, Walter Klepetko
16:05:00 Rational limits of extended operations for NSCLC Walter Klepetko
16:25:00 Adjuvant therapeutic possibilities in NSCLC Johan Vansteenkiste
16:45:00 VATS Lobectomy: state of the art Miha Sok
17:00:00 Proffered presentation
17:30:00 Company Sponsored Symposium - AstraZeneca Ltd.
19:15:00 Proffered presentation
19:30:00 Concert
Saturday, December 4, 2010
08:00:00 Meet the professor: Summary of new cytotoxic and targeted therapeutic strategies in NSCLC Nick Thatcher
09:00:00 Neuroendocrine tumors Pieter E. Postmus, Miha Sok
09:05:00 Small cell lung cancer - state of the art Pieter E. Postmus
09:25:00 Carcinoid tumor of the lung – state of the art Piero Ferolla
09:45:00 Proffered presentation
10:00:00 Proffered presentation
10:15:00 Proffered presentation
10:30:00 Coffee break
11:00:00 CELCC Honorary Lectures Lubos Petruzelka, Gyula Ostoros
11:05:00 Lung cancer in a historical setting Heine H. Hansen
11:30:00 Milestones in the chemotherapy treatment on non small cell lung cancer Jean Klastersky
12:00:00 Hot topics Robert Pirker, Judit Moldvay
12:05:00 Generic drugs or Biosimilars? Sandor Kerpel-Fronius
12:20:00 Maintenance therapy Tudor Ciulanu
12:40:00 Cost effectiveness and reimbursement of lung cancer treatment expenses in the region Zoltan Kalo
13:00:00 Discussion
13:30:00 Poster awards and Adieu
13:45:00 LUNCH
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.